Bendamustine Hydrochloride bulk supplier for pharma manufacturers

Bendamustine Hydrochloride 25 mg/vial, 100 mg/vial Suppliers & Bulk Manufacturers

Available Forms: Injection (powder for solution)

Available Strengths: 25 mg/vial, 100 mg/vial

Reference Brands: Treanda®, Bendeka®(US), Levact®(EU)

Bendamustine Hydrochloride is a chemotherapy drug used in the treatment of CLL and NHL, available as 25 mg and 100 mg IV infusions in the US and EU.

Get Enquiry / Request Bulk Quote

Usually answered within 48 hours | GMP documents shared before you commit

Manufacture or export Bendamustine Hydrochloride? List it or send an offer →

Product Description: Bendamustine Hydrochloride Injection, available in 25 mg and 100 mg vials, is a widely used oncology API and formulation for the treatment of chronic lymphocytic leukemia (CLL) and non-Hodgkin lymphoma (NHL). Marketed under brands like Treanda®, Bendeka®, and Levact® in the US and EU, it offers dual mechanisms of action—alkylation and antimetabolite activity—leading to potent cancer cell apoptosis. Ideal for pharmaceutical B2B sourcing, Bendamustine is supplied as a sterile powder or solution for IV infusion, suitable for hospitals and oncology treatment centers across regulated markets. GMP-certified manufacturing ensures quality compliance for international partnerships.

Bendamustine Hydrochloride — third party manufacturing & bulk supply

Bendamustine Hydrochloride 25 mg/vial, 100 mg/vial is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Bendamustine Hydrochloride is supplied as Injection (powder for solution) — an injectable dosage form, so the indicative MOQ is 50,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Bendamustine Hydrochloride listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Bendamustine Hydrochloride →

Usually answered within 48 hours, with matched manufacturers, indicative prices and document status.

Back to Listing

Frequently Asked Questions

Bendamustine Hydrochloride is listed as Injection (powder for solution) in 25 mg/vial, 100 mg/vial. Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

Bendamustine Hydrochloride is referenced against Treanda®, Bendeka®(US), Levact®(EU). Reference brands are shown for identification only and remain the property of their respective trademark owners.